These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7632720)
1. Different affinity of the two forms of human cytosolic thymidine kinase towards pyrimidine analogs. Munch-Petersen B; Tyrsted G; Cloos L; Beck RA; Eger K Biochim Biophys Acta; 1995 Jul; 1250(2):158-62. PubMed ID: 7632720 [TBL] [Abstract][Full Text] [Related]
2. Reversible ATP-dependent transition between two forms of human cytosolic thymidine kinase with different enzymatic properties. Munch-Petersen B; Tyrsted G; Cloos L J Biol Chem; 1993 Jul; 268(21):15621-5. PubMed ID: 8340387 [TBL] [Abstract][Full Text] [Related]
3. Human thymidine kinase 1. Regulation in normal and malignant cells. Munch-Petersen B; Cloos L; Jensen HK; Tyrsted G Adv Enzyme Regul; 1995; 35():69-89. PubMed ID: 7572355 [TBL] [Abstract][Full Text] [Related]
4. Enzyme kinetics of thymidine kinase isoenzymes of Ehrlich ascites tumour. He QM; Skog S; Welander I; Tribukait B Anticancer Res; 1990; 10(5A):1257-63. PubMed ID: 2241101 [TBL] [Abstract][Full Text] [Related]
5. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs. Wang L; Sun R; Eriksson S Antimicrob Agents Chemother; 2011 Jun; 55(6):2552-8. PubMed ID: 21444706 [TBL] [Abstract][Full Text] [Related]
6. Kinetic mechanism and inhibition of human liver thymidine kinase. Ellims PH; Van der Weyden MB Biochim Biophys Acta; 1981 Aug; 660(2):238-42. PubMed ID: 7284401 [TBL] [Abstract][Full Text] [Related]
7. Involvement of a substrate cycle between thymidine and thymidylate in the regulation of DNA precursor pool in ehrlich ascites tumour. He Q; Skog S Cell Physiol Biochem; 2002; 12(5-6):305-14. PubMed ID: 12438766 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286 [TBL] [Abstract][Full Text] [Related]
9. Valine, not methionine, is amino acid 106 in human cytosolic thymidine kinase (TK1). Impact on oligomerization, stability, and kinetic properties. Berenstein D; Christensen JF; Kristensen T; Hofbauer R; Munch-Petersen B J Biol Chem; 2000 Oct; 275(41):32187-92. PubMed ID: 10924519 [TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase in human leukemia--expression of three isoenzyme variants in six patients with chronic myelocytic leukemia. Munch-Petersen B Leuk Res; 1990; 14(1):39-45. PubMed ID: 2304355 [TBL] [Abstract][Full Text] [Related]
11. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Arnér ES; Spasokoukotskaja T; Eriksson S Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of 4'-azidothymidine. A compound with potent and selective activity against the human immunodeficiency virus. Chen MS; Suttmann RT; Wu JC; Prisbe EJ J Biol Chem; 1992 Jan; 267(1):257-60. PubMed ID: 1730594 [TBL] [Abstract][Full Text] [Related]
13. X-irradiation effects on thymidine kinase (TK): II. The significance of deoxythymidine triphosphate for inhibition of TK1 activity. He Q; Skog S; Welander I; Tribukait B Cell Prolif; 2002 Apr; 35(2):83-92. PubMed ID: 11952643 [TBL] [Abstract][Full Text] [Related]
14. Altered substrate and inhibitor specificity of purified human adult thymidine kinases (TK2) from leukemic cells. Munch-Petersen B; Völker C; Cloos L; Hofbauer R; Mortensen BT; Tyrsted G Adv Exp Med Biol; 1994; 370():253-6. PubMed ID: 7660901 [No Abstract] [Full Text] [Related]
15. Mitotic control of dTTP pool: a necessity or coincidence? Hu CM; Chang ZF J Biomed Sci; 2007 Jul; 14(4):491-7. PubMed ID: 17525869 [TBL] [Abstract][Full Text] [Related]
16. Tight binding of deoxyribonucleotide triphosphates to human thymidine kinase 2 expressed in Escherichia coli. Purification and partial characterization of its dimeric and tetrameric forms. Barroso JF; Elholm M; Flatmark T Biochemistry; 2003 Dec; 42(51):15158-69. PubMed ID: 14690426 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer. Agarwal HK; Khalil A; Ishita K; Yang W; Nakkula RJ; Wu LC; Ali T; Tiwari R; Byun Y; Barth RF; Tjarks W Eur J Med Chem; 2015 Jul; 100():197-209. PubMed ID: 26087030 [TBL] [Abstract][Full Text] [Related]
18. Reversible tetramerization of human TK1 to the high catalytic efficient form is induced by pyrophosphate, in addition to tripolyphosphates, or high enzyme concentration. Munch-Petersen B FEBS J; 2009 Jan; 276(2):571-80. PubMed ID: 19087190 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of thymidine kinase by P1-(adenosine-5')-P5-(thymidine-5')-pentaphosphate. Bone R; Cheng YC; Wolfenden R J Biol Chem; 1986 May; 261(13):5731-5. PubMed ID: 3457791 [TBL] [Abstract][Full Text] [Related]
20. Perturbation of ATP-induced tetramerization of human cytosolic thymidine kinase by substitution of serine-13 with aspartic acid at the mitotic phosphorylation site. Li CL; Lu CY; Ke PY; Chang ZF Biochem Biophys Res Commun; 2004 Jan; 313(3):587-93. PubMed ID: 14697231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]